Lulibrut Lotion contains Luliconazole 1% w/v, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole belongs to the imidazole class of antifungals, exerting its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The lotion formulation allows for easy application and rapid absorption into the affected area, providing effective local antifungal activity with minimal systemic exposure. Lulibrut Lotion is typically applied once daily to the affected skin regions after cleansing and drying, and treatment duration varies depending on the infection type, generally ranging from 1 to 4 weeks. It is well-tolerated, with adverse effects being rare and mostly limited to mild local irritation, burning, or itching at the application site. Caution is advised in patients with known hypersensitivity to luliconazole or any excipients. Lulibrut Lotion should not be used on mucous membranes or broken skin. As with all topical antifungals, adherence to the prescribed regimen is essential to ensure complete eradication of the infection and to prevent recurrence.